Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$1,669,800
-4.02%
Shares
Shares Volume: 30,000 Shares
Average Share Price: $55.66
INSIDER
Cheng Andrew
President and CEO (Director)
reported on Jan 29 2025
traded on Jan 27 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 716,062 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,481,115.5 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 47 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $609,942.74 |
| COMPANY PREVIOUS TRADES |